Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use

Cancer

Volumn 112, Issue 4, 2008, Pages 779-788

  Lairson, David R ^a   DiCarlo, Melissa ^b   Myers, Ronald E ^b   Wolf, Thomas ^b   Cocroft, James ^b   Sifri, Randa ^b   Rosenthal, Michael ^b   Vernon, Sally W ^a   Wender, Richard ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Colorectal cancer; Cost effectiveness; Economic evaluation; Screening promotion

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; GENERAL PRACTICE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; SCREENING TEST; STOOL BLOOD TEST; TELEPHONE; UNITED STATES; URBAN AREA;

AGED; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVENTIVE HEALTH SERVICES;

EID: 39049096409     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23232     Document Type: Article

References (45)

1. American Cancer Society. Cancer Facts and Figures. Atlanta, Ga: American Cancer Society; 2007.
2. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
3. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1471.
4. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-1371.
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-1607.
6. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
7. Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst. 2003;95:622-625.
8. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
9. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56:11-25.
10. U.S. Department of Health and Human Services. Healthy People 2010. Washington, DC: U.S. Department of Health and Human Services; 2000.
11. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129-131.
12. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - Update based on new evidence. Gastroenterology. 2003;124:544-560.
13. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311-1318.
14. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med. 2000;342:1766-1772.
15. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Prevalence Data: Adults Aged 50+ Who Have Ever Had a Sigmoidoscopy or Colonoscopy, 2004. Atlanta, Ga: Centers for Disease Control and Prevention; 2007.
16. National Center for Health Statistics. National Health Interview Survey Public Use Data File 2005. Atlanta, Ga: Centers for Disease Control and Prevention; 2006.
17. Maciosek M, Solberg L, Coffield A, Edwards N, Goodman M. Colorectal cancer screening: health impact and cost effectiveness. Am J Prev Med. 2006;31:80-89.
18. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:96-104.
19. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954-1961.
20. Myers RM, Sifri R, Hyslop T, et al. A randomized controlled trial of standard and tailored intervention impact on colorectal cancer screening. Cancer. 2007;110:2083-2091.
21. Andersen MR, Urban N, Ramsey S, Briss PA. Examining the cost-effectiveness of cancer screening promotion. Cancer. 2004;101:1229-1238.
22. Pasick RJ, Hiatt RA, Paskett ED. Lessons learned from community-based cancer screening intervention research. Cancer. 2004;101(5 suppl):1146-1164.
23. Chirikos TN, Christman LK, Hunter S, Roetzheim RG. Cost-effectiveness of an intervention to increase cancer screening in primary care settings. Prev Med. 2004;39:230-238.
24. Wolf MS, Fitzner KA, Powell EF, et al. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among veterans. J Clin Oncol. 2005;23:8877-8883.
25. Rawl SM, Menon U, Champion VL, et al. Do benefits and barriers differ by stage of adoption for colorectal cancer screening? Health Educ Res. 2005;20:137-148.
26. Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000;9:229-232.
27. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for 6 cancer screening procedures. J Natl Cancer Inst. 1993;85:566-570.
28. Lairson DR, Chang YC, Bettencourt JL, Vernon SWGA. Estimating development cost for a tailored interactive computer program to enhance colorectal cancer screening compliance. J Am Med Inform Assoc. 2006;12:476-487.
29. U.S. Department of Labor, Bureau of Labor Statistics. Consumer Price Index, 2006. Washington, DC: U.S. Department of Labor, Bureau of Labor Statistics; 2007.
30. Andersen MR, Hager M, Su C, Urban N. Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities. Health Educ Behav. 2002;29:755-770.
31. Glick HA, Polsky DP, Schulman KA. Trial-based economic evaluations: an overview of design and analysis. In: Drummond M, McGuire A, eds. Economic Evaluation in Health Care. Oxford, United Kingdom: Oxford University Press; 2001:113-140.
32. Mant D, Fuller A, Northover J, et al. Patient compliance with colorectal cancer screening in general practice. Br J Gen Pract. 1992;42:18-20.
33. Goldberg D, Schiff GD, McNutt R, Furumoto-Dawson A, Hammerman M, Hoffman A. Mailings timed to patients' appointments: a controlled trial of fecal occult blood test cards. Am J Prev Med. 2004;26:431-435.
34. Dietrich AJ, Tobin JN, Cassells A, et al. Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial. Ann Intern Med. 2006;144:563-571.
35. Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004;96:770-779.
36. Marcus AC, Mason M, Wolfe P, et al. The efficacy of tailored print materials in promoting colorectal cancer screening: results from a randomized trial involving callers to the National Cancer Institute's Cancer Information Service. J Health Commun. 2005;10(Suppl 1):83-104.
37. Lipkus IM, Skinner CS, Dement J, et al. Increasing colorectal cancer screening among individuals in the carpentry trade: test of risk communication interventions. Prev Med. 2005;40:489-501.
38. Basch CE, Wolf RL, Brouse CH, et al. Telephone outreach to increase colorectal cancer screening in a urban minority population. Am J Public Health. 2005;96:2246-2253.
39. Rimer BK, Halabi S, Sugg Skinner C, et al. Effects of a mammography decision-making intervention at 12 and 24 months. Am J Prev Med. 2002;22:247-257.
40. Kreuter MW, Skinner CS, Steger-May K, et al. Responses to behaviorally vs culturally tailored cancer communication among African American women. Am J Health Behav. 2004;28:195-207.
41. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:406-1422.
42. Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999;14:432-437.
43. Sheikh RA, Kapre S, Calof OM, Ward C, Raina A. Screening preferences for colorectal cancer: a patient demographic study. South Med J. 2004;97:224-230.
44. Dolan NC, Ferreira MR, Fitzgibbon ML, et al. Colorectal cancer screening among African-American and white male veterans. Am J Prev Med. 2005;28:479-482.
45. Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med. 2000;133:761-769.